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A DNA fragment contammg the human corttcotropm releasmg hormone (CRH) gene. along with 9 kb of upstream and 4 kb of downstream se- 
quences, was Isolated from a human genomtc DNA hbrary. Nucleottde sequence analysis of the proxtmal 918 nucleotides 5’ flanking the putattve 
major mRNA start site of the human gene and compartson to the 866 nucleottde long homologous ovine sequence, revealed that this region of 
the CRH gene consists of two distmct areas wtth different degrees of homology, varymg from 7296 to 9496 The putative functtonal features of 
the human sequence were tdenttfied. Many. but not all. features were conserved m the ovme sequence. The highly conserved nature of the regulatory 
regton of thts gene makes It a good candtdate for tracmg posstble related genettc defects of the hypothalamic-pttmtary-adrenal (HPA) axts 
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1. INTRODUCTION 
Corticotropin releasing hormone (CRH), a 41 amino 
acid peptide, plays a pivotal role in the maintenance of 
homeostasis and in the adaptive response to stress 
[l-3]. Both hypersecretion and hyposecretion of CRH 
have been described, respectively, in patients with ma- 
jor psychiatric disease, such as depression and anorexia 
nervosa [4,5], and in a rat model of autoimmune ar- 
thritis [6,7]. The CRH gene directs the biosynthesis of 
hypothalamic, suprahypothalamic and placental pre- 
proCRH, by complex transient and/or tissue-specific 
regulatory mechanisms [g-12]. Understanding these 
mechanisms is a prerequisite to a thorough comprehen- 
sion of CRH regulation at the basal and stress states 
and its potential role in the pathophysiology of human 
disease. 
isolated a clone from a human genomic DNA library 
which contains the CRH gene and 9 kb of its upstream 
and 4 kb of its downstream flanking portions. We se- 
quenced the proximal 918 nucleotides 5 ’ flanking the 
putative proximal mRNA start site of the human CRH 
gene and compared it with that of the ovine gene [14]. 
The 5’ flanking regions of both genes consist of two 
distinct areas of sequence homology. The 334 base-long 
one, proximal to the mRNA start site, with 94% 
homology and the remaining upstream sequence with 
‘72% homology. The putative functional features of the 
regulatory region of the human CRH gene are reported 
along with their extent of preservation at homologous 
positions of the ovine CRH sequence. 
2. MATERIALS AND METHODS 
We undertook to delineate the structure of the 
regulatory region of the human CRH gene as a first step 
in tracing possible genetic defects of the hypothalamic- 
pituitary-adrenal (HPA) axis. Previous work revealed 
that the first 330 based 5’ flanking the human, ovine 
and rat CRH genes had a higher degree of homology 
than their protein-coding regions [ 13,141. To define the 
limits of the highly conserved 5’ flanking segment, we 
2.1. Genomrc library screenmg and Southern blot analysts 
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The human genomic DNA library, constructed in a charon 30 vec- 
tor [15], has been previously described [16,17]. The probe used for 
screening was a synthetic 4%mer oligodeoxynucleotide complemen- 
tary to human CRH mRNA [9]. This oligomer was radiolabeled at its 
5’ end with [y-P3*]ATP (3000 Wmmol, ICN) and T4 polynucleotide 
kinase, using standard procedures [18]. The radiolabeled probe was 
purified by Sephadex G-50 gel filtration and was used throughout the 
identification, purification and characterization of the human CRH 
gene-containmg genomic clone. The specific activity of the column- 
purtfied oligonucleottde probe was 2x 10’ cpm/nmol. All the 
prehybrtdizations and hybridtzations were done at 42°C in a solution 
‘containing 1 M sodium chloride, 50% formamide and 10% dextran 
sulfate (Pharmacia), pH 7. Only the prehybridization solutions con- 
tained 100 /g/ml boiled and sonicated salmon sperm DNA carrier. 
Prior to autoradiography, the blots were washed twice at 55°C for 30 
min to a final stringency of 2 times standard saline citrate/O.l% 
sodium dodecyl sulfate. The BstEII-dtgested DNA, used as a size 
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standard, was radtolabeled at the 3’ ends with the Klenovv fragment 
of DNA polymerase using [a-3’P]dGTP (800 Ci/mmol, ICN) as the 
label, as described m [18] 
2.2. DNA sequencing 
The hybridizing 3.8 kb Hind111 fragment containing the human 
CRH gene [19], was subcloned at both ortentations on a bluescript 
plasmid vector (Stratagene). DNA sequencmg was performed using 
T7 DNA polymerase and dideoxy-termination reactions [20]. It was 
carried out wtth a commerctal kit (US Biochemicals, ktt version 2.0), 
using [e-%]dATP (1000 Ct/mmol, Amersham), as the label. Se- 
quencing of both strands was performed using the following CRH- 
specific primers: 5 ’ GAGATTTCCCAAGTGTG3 ’ , 5 ’ CAACCA- 
CATAAAGGAG3 ’ , and 5 ’ GATGTTCCTGCACAC3 ’ , m addition 
to the T3 primer. 
2.3. Material5 
Most of the biological reagents were obtained from Bethesda 
Research Laboratories and Boehringer Mannheim and the solutions 
were prepared by the NIH media unit using published formulations 
1181. 
3. RESULTS AND DISCUSSION 
A genomic DNA library derived from human placen- 
tal DNA was screened with an oligonucleotide probe 
complementary to human CRH mRNA corresponding 
to amino acids 22-37 of the published sequence [19]. 
From about 1.5 x lo6 recombinant plaques screened 
[21], one hybridization-positive clone was isolated. The 
isolate had a 15 kb DNA insert containing the 3.8 kb 
Hind111 fragment that carries the human CRH gene. 
Specifically, it had 9 kb of upstream and 4 kb of 
downstream sequences surrounding the gene. Fig. 1 
shows the Hind111 map of the clone, as derived by 
hybridization to the CRH oligomer prober after restric- 
tion digestion, agarose gel electrophoresis, and 
Southern transfer of the resulting fragments. The 
hybridizing 3.8 kb Hind111 fragment was subcloned in 
a bluescript plasmid vector and the sequence of the 918 
base-long 5’ flanking region of the gene was determin- 
ed (Fig. 2). 
The sequence of the 918 base-long 5’ flanking por- 
tion of the human CRH gene has been previously deter- 
mined up to - 334 [19]. The regulatory features of the 
latter, which include the two highlighted TATAA and 
three CAAT boxes and CAMP response element, have 
been previously identified. It appears that both pro- 
moters are active in human placenta and in mouse cor- 
ticotroph tumor cells stably transfected with the human 
gene, and that the distal upstream promoter is less effi- 
ciently utilized than the proximal one [22,23]. The 
homologous rat CAMP response element had also been 
shown to be functional in transient and stable expres- 
sion systems [24,25]. 
The highlighted polypurine tract at - 829, previously 
identified at the - 801 position of ovine CRH [14], is 
also present in the -400 bp 5’ flanking region of the 
proopiomelanocortin [26] and rat growth hormone 
genes [27], as well as in the mouse mammary tumor 
virus [28]. A functional role for this conserved sequence 
has yet to be assigned. A long open reading frame in the 
same direction with the CRH coding strand exists star- 
ting from nucleotide - 597 and ending at -224. It 
A. 
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9 kb 
Hind III Hind III Hind III 
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Fig. I. Positive identification and characterizatton of the human CRH gene containing genomic DNA isolate. (A) The Hind111 map showing the 
location of the CRH gene and the extent of its flankmg regions m the clone. The bent arrow points to the directton of transcription. The 3.8 kb 
Hind111 fragment subcloned in the plasmid vector is shown hatched. (B) Southern blot hybrtdization analysis of the HlndIIl-digested hybridization- 
posttive recombinant phage. (I) Picture of ethidmm bromide stamed gel. (II) Autoradiogram of blotted gel hybridized with the human CRH 
oligonucleotide probe. Lane M contains the BstEll-digested DNA markers. Lane CRH contams the HlndIll-digested recombmant phage DNA. 
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5’.> 
900 850 
AAGCTTGmAACTCATGCATCTCTCACTGGCCGCCTCTCTC~~~GGG~TAG~GGGAGTCCAC 
800 
AATTAATTTTAGATTGTGAGAAGAGAGACAAAAAAAGGAGCAGAGAGTTTCTGAGATAACCTAAAAT 
-750 
CrTTGCCGCACCCC~ACTACCCCGGTTTGTGTGCCCC~CACTATGGGAGTAGCTC~GTCATCATCT~A 
700 650 
ACTTGAACTGCA‘TTTTGAGAGAlTTATTGGCCrrGCTTC 
600 
GGGAGGAAAAAGCAGATAGACGTrrAAAAGCTGGATGTTCTGCACACCCCTCTCCTGATGC7TCATTCT~T 
550 500 
CCAGGCAGAAAGATGGTGGGACTCTGTCTCTAGCAAAGGGGATA~CCAGATACTGAGGTG~GTCAGAGAC 
-450 
ACCTGGTCAGGGAGG~AGGAGAAGGGGCATCCAGGTCCACCC~TCC~CT~CT~CTGCTGC~CCT~ 
400 ,350 
CAGGGCTGCACTGGGACACCTCACTTCC~CCCAC~CCCC~CCTCCTCCCA~CGCTGTC~C~GCACACC 
-300 
CCTAATATGGCCmCATAGTAGAGGTCAATATG~CACACTTGGG~TCTCATTC~G~~~GT 
-250 
CAATGGACAAGTCATAAGAAGCCC~CCA~TAGGGCTC;G~GACGTCA~C~GAGGCGAT~TATCT 
-150 
GTTGATATAAA~GGATGTGAGA~CAGATAGCAGGCAGGGCCC 
-100 
TATGAmATGCAGGAGCAGAGGCAGCACGCAATCGAGCTGTC~GAGAGCGTCAGCTA~AGGC~TGC 
50 1 
TGCGTGG~GAAGAGGGTCGACACTAT~TCCCAClCCAGGCTCTGGAGTGG 
Fig. 2. Nucleotide sequence of the complete 5’ flanking region of the human CRH gene within the subcloned 3.8 kb Hind111 fragment. The 
sequences in bold type letters are the standard regulatory signals of the gene, and the polypurine tract at -829 is a highly conserved feature common 
to many genes. The sequence shown is colinear to the CRH mRNA coding strand. Underlined is the cyclic AMP-responsive element sequence 
consensus. 
could potentially code for a 125 amino acid-long pep- 
tide. Such a long reading frame is not preserved in the 
ovine gene. Other short open reading frames exist in the 
human CRH gene which could code for a maximum of 
35 amino acids. Comparison of the regulatory region of 
the human CRH sequence with other sequences from 
the gene bank revealed a small degree of homology with 
the proximal ( - 300 bp) 5 ’ regulatory region of several 
genes, including mink and bovine proopiomelanocortin 
(POMC). No sequence repetitions or highly repetitive 
AluI type DNA sequences were identified. 
A remarkable structural feature of the CRH gene is 
the unusually high degree of inter-species sequence 
homology found in its 5 ’ flanking region [13,14,25]. To 
define the limits of the highly conserved 5’ flanking 
area, we aligned the human and ovine sequences 
(Fig. 3A). This marked the boundaries of two distinctly 
conserved regions: regulatory flanking region 1 (RFR 
l), with 94% sequence homology, and the adjoining 
regulatory flanking region 2 (RFR 2), with 72% se- 
quence homology. The degree of homology found in 
the 5 ’ RFR 2 of the human CRH gene is similar to that 
of the 300 bp 5’ flanking regions of other genes, such 
as the human-mouse and human-bovine POMC [26]. 
Fig. 3B gives a schematic representation of the two 
Fig. 3. Alignment of all known CRH regulatory sequences. (A) The 
human and ovine CRH regulatory sequences were aligned to allow 
maximal degree of homology. They are displayed in two segments, 
RFR 1 with 94%, and RFR 2 with 72% overall homologies. The 
human-rat alignment over the RFR 1 segment is also shown. (B) 
Schematic representation of human RFR 1 and RFR 2 segments, and 
their percent homology to ovine segments. 
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RFR segments linkered by a 13 bp fragment in the 
human gene that is not present in the ovine one. The 
high and unusually extended homology of the human 
CRH 5’ flanking region up to or more than 0.9 kb sug- 
gests that the regulation of this gene is complex and in- 
fluenced by multiple factors. Further upstream 
sequencing would be important to define the borders of 
the regulatory region of this gene. 
Glucocorticoids have been unequivocally shown to 
down-regulate rat and ovine hypothalamic CRH 
mRNA production [14,29,30] and CRH secretion [12]. 
Interestingly, however, human placental CRH expres- 
sion was up-regulated by glucocorticoids [9-l 11. 
Although the mechanisms for this phenomenon are still 
obscure, it is clear that the CRH gene is regulated by 
glucocorticoids and should contain in its 5’ flanking 
segment sequences homologous to the steroid receptor 
binding site consensus [32-341. In the 5 ’ RFR 2 of the 
ovine CRH gene sequence, three such putative signals 
have been proposed based on their homology to the 
consensus sequence of one of the two DNA binding 
zink fingers of the glucocorticoid receptor [33]. These 
sites, however, have not been preserved in the human 
sequence, neither is any other new site identifiable with 
the proposed CRH ‘consensus’ sequence TGTTCT. In 
addition, no absolute homology to any other steroid 
receptor binding consensus sequence was found. Such 
sites, if present, might reside further upstream and their 
identification and localization will require further se- 
quencing and appropriate functional assays. 
Search for other signal sequences, revealed nine c- 
jun/AP-1 binding sites, two CP-1 sites, one CTF, and 
four CACCC sites. Many of these sites are preserved at 
A. 5’.> 
homologous positions in the ovine CRH sequence. No 
recognizable sites for Spl, mammalian enhancer 
binding protein (C/EBP), AP-2, octamer transcription 
factor OCT-1 or -2, pituitary factor (pit-l) or serum 
response factor @RF) were found [33-351. Fig. 4, 
displays a composite of these sites in the upstream 
region of the human CRH gene. The abundance of c- 
jun/AP-1 sites, together with their preservation at 
homologous positions of the ovine gene, is consistent to 
the experimentally demonstrated inducibility of the 
CRH gene by phorbol esters and epidermal growth fac- 
tor [17,36] (and our unpublished results from transient 
expression studies). It is interesting to note that the 
CACCC transcription factor appears, under certain 
conditions, to act synergistically with steroid receptors 
eliciting strong responses to glucocorticoid stimulation 
[34]. The CACCC sites found in the human sequence, 
including the one conserved in the ovine gene, are 
located in the more heterogeneous RFR 2 domain. It is 
possible that this binding site might be involved in 
steroid regulation, if indeed the long sought after 
steroid response element is located further upstream. 
We conclude that the 918 base-long 5’ regulatory 
region of the human CRH gene consists of two distinct 
areas with different degrees of evolutionary change. 
The highly conserved nature of the regulatory region of 
this gene makes it a good candidate for tracing possibly 
related genetic defects of the HPA axis. Although con- 
sensus sequences for several regulatory factors were 
recognised, the complexity of CRH regulation in vivo 
suggests that additional CRH cis regulatory elements 
may exist and for their identification further cloning 
and functional assays will be required. 
AAGCTTGmAACTCATGCATCTCTCACTGGCCGCCTCTCTCT~~~TGGG~TAG~AGGGAGTCCAC 
AArrAATTTTAGATTGTGAGAAGAGAGACAAAAAAAGGAGCAGAGAGTTTCTGAGATAACCTAAAATCTT 
GGGAGGAAAAAGCAGATAGACGT~~AGCTGGATGTTCTGCA~CTCTCCTGATGC~CATTCT~T 
CCAGGCAGAAAGATGGTGGGACTCTGTCTCTAGCAAAGGGGATA~CCAGATACTGAGGTGrl~GAGAC 
ACCTG~GGGAGGrTAGGAGAAGGGGGCATCCAGGTC~CCTCC~CTGGCTGGCTGCTGC~CCTGG 
CAGGGCTGCACTGGGACACCTCACTlCmCCCACTCCCACTCCCCC~CCTCCTCCCA~CGCTGTC~C~GCA~ 
ECTAATAT <- RFR 2 
GGCC~TCATAGTAAGAGGTATG~~CACAC~GGG~TCTCA~C~GAA~~~TGGA 
CAA~TAAGAAGCCCTlCCATTTTAGGGGCTCG TIQWGTCACCAAGAGGCGATAAATATCTG~GATA 
TAA~ATGTGAGA~CAGTGTTGAGAGATAGC~~CTGCCCCTCG~CC~GGCAGGGCCCTATGA~ 
TATGCAGGAGCAGAGGCAGCACGCAATCGAGCT~~GAGC~GCTA~AGGC~TGCTGCGT~ 
TTTTTGAAGAGGTCGACACTATAAAATCCCACTCCAGGCTCTGGAGTGG <- RFR 1 
B. Bmdmg SW # of wes #J of sltes preserved I” o”,“e 
GCCAAT 1 "One 
CCAAT 2 1 
CACCC 4 1 
TGAUGTCA 9 7 
TGACGTCAC 1 1 
Fig. 4. Regulatory signals in the 5’ RFR 1 and RFR 2 of human CRH gene. (A) The positions of putattve consensus bmding sites found for 
transcription factors are underlined and those preserved in the ovine gene are typed in bold face letters. The broken superscript line marks the 
nonpreserved sequences in the ovine GCCAAT site. (B) List of the type and number of binding sites found in the human CRH gene and their 
respecttve ovine counterparts. The sites shown are for the transcription factors CTF/NPl, CPl, CACCC, c-Jun/AP-1 and CREB, respectively. 
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